China · Delayed Price · Currency is CNY Huaren Pharmaceutical Statistics
Total Valuation
SHE:300110 has a market cap or net worth of CNY 3.09 billion. The enterprise value is 3.78 billion.
| Market Cap | 3.09B |
| Enterprise Value | 3.78B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300110 has 1.18 billion shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 1.18B |
| Shares Outstanding | 1.18B |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 9.56% |
| Float | 886.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 7.93 |
| P/FCF Ratio | 12.75 |
| P/OCF Ratio | 11.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.42, with an EV/FCF ratio of 15.62.
| EV / Earnings | n/a |
| EV / Sales | 3.10 |
| EV / EBITDA | 19.42 |
| EV / EBIT | 39.49 |
| EV / FCF | 15.62 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.91.
| Current Ratio | 0.85 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 4.40 |
| Debt / FCF | 3.54 |
| Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is -41.27% and return on invested capital (ROIC) is 5.87%.
| Return on Equity (ROE) | -41.27% |
| Return on Assets (ROA) | 1.96% |
| Return on Invested Capital (ROIC) | 5.87% |
| Return on Capital Employed (ROCE) | 6.59% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | 478,287 |
| Profits Per Employee | -192,454 |
| Employee Count | 2,549 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 3.36 |
Taxes
In the past 12 months, SHE:300110 has paid 8.06 million in taxes.
| Income Tax | 8.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.89% in the last 52 weeks. The beta is 0.38, so SHE:300110's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -26.89% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 40.18 |
| Average Volume (20 Days) | 45,517,512 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300110 had revenue of CNY 1.22 billion and -490.57 million in losses. Loss per share was -0.42.
| Revenue | 1.22B |
| Gross Profit | 399.88M |
| Operating Income | 95.68M |
| Pretax Income | -479.12M |
| Net Income | -490.57M |
| EBITDA | 194.09M |
| EBIT | 95.68M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 233.38 million in cash and 855.36 million in debt, with a net cash position of -621.97 million or -0.53 per share.
| Cash & Cash Equivalents | 233.38M |
| Total Debt | 855.36M |
| Net Cash | -621.97M |
| Net Cash Per Share | -0.53 |
| Equity (Book Value) | 935.38M |
| Book Value Per Share | 0.73 |
| Working Capital | -189.56M |
Cash Flow
In the last 12 months, operating cash flow was 261.93 million and capital expenditures -19.98 million, giving a free cash flow of 241.95 million.
| Operating Cash Flow | 261.93M |
| Capital Expenditures | -19.98M |
| Depreciation & Amortization | 98.41M |
| Net Borrowing | -208.71M |
| Free Cash Flow | 241.95M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 32.80%, with operating and profit margins of 7.85% and -40.24%.
| Gross Margin | 32.80% |
| Operating Margin | 7.85% |
| Pretax Margin | -39.30% |
| Profit Margin | -40.24% |
| EBITDA Margin | 15.92% |
| EBIT Margin | 7.85% |
| FCF Margin | 19.85% |
Dividends & Yields
SHE:300110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.01% |
| Earnings Yield | -15.91% |
| FCF Yield | 7.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on May 31, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 31, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300110 has an Altman Z-Score of 1.28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 5 |